First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report
{{output}}
Aims: Evaluate the efficacy and safety of faricimab for treatment-naïve and pre-treated diabetic macular oedema (DME) in a real-world setting. Methods: ... ...
